(2S,3S)-Ethyl 3-aminobicyclo[2.2.2]octane-2-carboxylate hydrochloride, 97.0%, 25g

1-Pyrrolidin-3-(2'-chlorophenyl)-3-(N-Cbz-N-methyl)amino-propane, 97.0%, 250mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket GL connecting piece, DN 100, 1000 ml, 130 mm, 1 Piece

2-(2-ethyl-1H-imidazol-1-yl)ethanol, 95.0%, 1g

2-(4-(Benzyloxy)-3,5-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

tert-Butyl cyclobutanecarboxylate, 98%, 1g

3-[(propylamino)methyl]phenol, 95.0%, 10g

tert-Butyl 2-amino-4-oxo-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate, 97%, 5g

3,5-Bis(tert-butyldiphenylsilyloxy)benzyl Alcohol>95.0%(GC)1g

3,4-Dimethylbenzyl bromide, 95.0%, 1g

(2Z)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-yl]-1-(2,4,5-trifluorophenyl)but-2-en-2-amine, 95%, 5g

3-Azido-propylamine, 95.0%, 250mg

N-[3-(methylthio)phenyl]guanidine, 95.0%, 500mg